Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
ID07001059

Optic Nerve Sheath Evaluation in Giant Cell Arteritis by Ultrasound

Led by Hôpital NOVO · Updated on 2025-09-12

190

Participants Needed

9

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Giant Cell Arteritis (GCA) is a rare inflammation of large and medium-sized blood vessels, mainly affecting women around 70 years old. This research aims to evaluate if measuring the optic nerve sheath diameter (ONSD) by ultrasound can serve as a reliable diagnostic marker for GCA. Early and accurate diagnosis of GCA is crucial, as current recommended tests include imaging and temporal artery biopsy, which can be affected by prior corticosteroid treatment. Participants suspected of having GCA will undergo orbital ultrasound at the start of the study and again at six months if GCA is confirmed. This ultrasound method is non-invasive, widely available, and cost-effective, offering a potentially faster way to diagnose GCA. The study focuses on measuring the optic nerve sheath thickness to assess its diagnostic value. During the study, patients will receive orbital ultrasounds at enrollment and possibly after six months. Researchers will measure the optic nerve sheath diameter, assess its reproducibility, and study changes under treatment. They will also explore how this measurement relates to other GCA features such as extracranial involvement and visual symptoms. The primary outcome is the accuracy of the optic nerve sheath measurement at these time points for diagnosing GCA.

CONDITIONS

Brief Title

oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with suspected Giant Cell Arteritis
  • Patient aged 50 years or older
Not Eligible

You will not qualify if you...

  • History of Giant Cell Arteritis
  • History of polymyalgia rheumatica without initial PET scan
  • History of retinal disease, demyelinating disease, or intracranial hypertension
  • Use of corticosteroids greater than 0.5 mg/kg in the last 2 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Diagnostic Evaluation

Duration - At enrollment (Day 0)

Participants undergo orbital ultrasound at the beginning of their participation to evaluate the optic nerve sheath diameter as a diagnostic marker for Giant Cell Arteritis (GCA).

1 visit (in-person) at enrollment

Long-term Monitoring

Duration - 6 months after enrollment

Participants with confirmed suspicion of GCA after initial tests have a follow-up orbital ultrasound at 6 months to assess the evolution of the optic nerve sheath diameter under treatment.

1 follow-up visit (in-person) at 6 months

Trial Site Locations

Total: 9 locations

1

Rhumatology departement - Centre Hospitalier Aix en Provence

Aix-en-Provence, France

Not Yet Recruiting

2

Rhumatology department - Centre Hospitalier Universitaire de Brest

Brest, France

Not Yet Recruiting

3

Internal Medecine Department- CHU Caen

Caen, France

Actively Recruiting

4

Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon

Dijon, France

Not Yet Recruiting

5

Internal Medicine and VascularMedecine Department - Centre Hospitalier Universitaire de Nantes

Nantes, France

Not Yet Recruiting

6

Internal Medicine department - Hôpital Saint-Antoine

Paris, France

Not Yet Recruiting

7

Rhumatology department - Hôpital Bichat

Paris, France

Not Yet Recruiting

8

Rhumatology department - Hôpital NOVO - Pontoise site

Pontoise, France

Not Yet Recruiting

9

Rhumatology department - Centre Hospitalier Universitaire de Tours

Tours, France

Not Yet Recruiting

Loading map...

Research Team

M

Maryline DELATTRE

M

Mathilde WLODARCZYK

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Investigating the Role of Hematopoietic Mutations and Mosaic...

Giant Cell Arteritis (GCA)

Actively Recruiting

1 location

CARe RAiSE Study - Clinical Assessment for Rheumatologic Dis...

Rheumatic Diseases

Actively Recruiting

1 location

Dapagliflozin and Endothelin Receptor Antagonism in Large Ve...

Large Vessel Vasculitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here